Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
Dima Shulkin: Emerging Biomarkers for Early Prediction of Sepsis-Induced Shock
Dima Shulkin/LinkedIn
May 24, 2026, 03:31

Dima Shulkin: Emerging Biomarkers for Early Prediction of Sepsis-Induced Shock

Dima Shulkin, Co-Founder and CTO at RobotDreams GmbH, shared a post on LinkedIn about a recent article by Jia Li et al, published in Frontiers in Pharmacology, adding:

“Could a blood test warn doctors hours before a sepsis patient takes a dangerous turn?

A 2026 review in Frontiers in Pharmacology by Li and colleagues explores that hope.

Sepsis is the body’s runaway reaction to infection.

When it goes far enough, blood pressure crashes and organs fail.

In some intensive care units, more than 4 in 10 of these patients die.

The authors look at tiny ‘warning signals’ in the blood that rise before the usual symptoms.

In one cited study of 142 patients, a signal called IL-6 correctly flagged the high-risk patients about 80 percent of the time.

Most signals still need testing before doctors can fully trust them.”

Title: Early biomarkers for predicting sepsis-induced shock: insights from inflammatory pathways and immune response

Authors: Jia Li, Qiufang Zhao, Haiyun Gao, Hongjun Wang, Cong Guo, Xiaoling Feng

Dima Shulkin: Emerging Biomarkers for Early Prediction of Sepsis-Induced Shock

Stay updated on all scientific advances with Hemostasis Today.

Cong Guo Dima Shulkin Frontiers in Pharmacology Haiyun Gao Health Hematology Hemostasis Hemostasis News Hemostasis Today Hongjun Wang IL-6 Jia Li Medicine Qiufang Zhao Sepsis Shock Xiaoling Feng
NewsFeed